
Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk
Feb 14, 2024 - 00:11:56
Radio and PodcastLive Radio & Podcasts
This is a special episode brought to you in association with Hepatology Knowledge into Practice. NASH occurs in around 20% of individuals with NAFLD, and puts patients at high risk of poor outcomes including cardiovascul...